跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ATORVASTATINA PENSA PHARMA 30 MG COMPRIMIDOS RECUBIERTOS CON PELICULA - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
ATORVASTATINA PENSA PHARMA 30 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Approved
STANDARD
ATORVASTATINA PENSA PHARMA 30 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Towa Pharmaceutical S.A.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Aug 28, 2023
Approval ID
9eac9e77e1f24154
Company
Towa Pharmaceutical S.A.
Type
Standard
Approval Details
Approval Id
9eac9e77e1f24154
Drug Cima Aemps Name
ATORVASTATINA PENSA PHARMA 30 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Register Number
89026
Holder Company Name
Towa Pharmaceutical S.A.
Marketing Company Name
Towa Pharmaceutical S.A.
Authorization Date
2023-08-28
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
30 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Towa Pharmaceutical S.A.
Active Ingredients
ATORVASTATINA CALCICA TRIHIDRATO
32,49 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Aug 28, 2023
Approval ID
9eac9e77e1f24154
Type
Standard
Back to CIMA-AEMPS Approvals